Dicot Pharma AB

A great start to 2025! Today we are delighted to welcome Ninus Caram-Lelham as our CMC Director. This is a new role at Dicot Pharma, where Ninus will be in charge of developing and implementing our strategies within chemistry, manufacturing, and controls (CMC for short). Ninus has a PhD in Pharmaceutical Chemistry and brings solid experience from related, senior roles at the Swedish Medical Products Agency, Q-Med, and Ilya Pharma, among others. #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

🎄The Christmas edition of DICOTnews is here, summarizing key events last two months and wrapping up an incredible year. Catch Elin’s holiday message and the Nasdaq First North listing ceremony on video, and much more! Read DICOTnytt in Swedish here: https://lnkd.in/d9qa94-P And now, introducing DICOTnews in English: https://lnkd.in/d-PqCmVX

And the American IP success story continues. The second patent in a key patent family is now granted in the U.S. with the third already confirmed for approval on December 24th by the United States Patent and Trademark Office. This means our gift from Santa this year will be strenghtened product and method protection in the U.S. until 2042. Now that´s what we call a Merry Christmas. Read the press release here: https://lnkd.in/dXw6Ep2a #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

In February, we return to the ESSM Congress, this time joined by Professor François Giuliano. He will present the findings from our Phase 1 study as well as the study design for Phase 2a. "LIB-01 has the potential to become a game changer in the landscape of the medical treatment for erectile dysfunction. Sharing this with the European medical community is very exciting,” comments Professor Giuliano. The European Society for Sexual Medicine is Europe’s leading scientific organization in sexual medicine. Its annual congress brings together some of the world’s foremost experts in the field. This year’s event will take place at the historic University of Vienna, February 20–22. #ESSM #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

One granted, two to go. A few weeks ago, the US Patent and Trademark Office issued a Notice of Allowance for three of our patent applications. Now, the first one has received its final approval. This patent covers key steps in the manufacturing process of LIB-01 and extends our protection in the US until 2042. #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

We just became much stronger. Today we are proud to introduce international business development expert Håkan Wickholm as he joins the management team as our new Chief Business Officer. Håkan adds vital global experience to our future commercialization through multiple executive roles in AstraZeneca such as Business Development Director for Europe, the Middle East, and Africa and CEO in the Gulf States. But also from CEO and CBO positions in smaller companies in the development stage. Want to hear what Håkan has to say about this? Go here: https://lnkd.in/dmV5mQT4 #businessdevelopment #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

Now we’re underway! The first participants have been dosed in our Phase 2a study. Among the six clinics across Sweden, Denmark, and the Netherlands, it was Stockholm and Gothenburg who were the first ones out. We are now entering an intensive period of ongoing recruitment, and the ones participating will receive doses for three consecutive days and then be monitored during eight weeks to evaluate efficacy and safety. #clinicaltrials #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

Yesterday, during our bell ceremony at Nasdaq, the development team, led by CSO Charlotta Gauffin, simultaneously launched the phase 2a study, through our skilled clinical partner CTC. Primary goal: to evaluate the efficacy of LIB-01 in patients with erectile dysfunction. Recruitment began immediately following regulatory approval about two weeks ago. Now, the study has officially commenced, as the first screening visit is completed. Recruitment often risks delaying clinical trials, but we’ve seen strong interest from individuals eager to participate. This not only boosts our confidence in a smooth study execution but also stands as a testament to the importance of our work in combating erectile dysfunction. Read more about the study start here: https://lnkd.in/dAfRtgvY #clinicaltrials #clinicaltrialconsultants #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

Nasdaq First North – Dicot Pharma has arrived! Today marks a major milestone in accelerating our international presence. Together with all who joined us, we made this day a powerful memory to carry with us as we continue our journey.   A big thank you to Nasdaq for a great listing ceremony. #nasdaq #nasdaqfn #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning

Just one day to go! Tomorrow, we celebrate our first day on Nasdaq First North with a traditional ceremony featuring a brass bell from 1798. Join us for the live-streamed event and catch Elin's on-stage interview by clicking here: https://lnkd.in/dsPiMBva. The broadcast begins at 8:45 am.   Ahead of this milestone, Elin spoke with Direkt Studios to share her perspective on the significance of the listing and what lies ahead for our company. Watch the interview below. #nasdaq #pharma #pharmaceutical #drugdevelopment #sexualdysfunctions #erectiledysfunction #prematureejaculation #lifescience #kliniskastudier #läkemedelsutveckling #sexuelladysfunktioner #erektionssvikt #tidigutlösning